Literature DB >> 22808447

Are antidepressants effective in the acute and long-term treatment of depression? Sic et Non.

Ronald Pies1.   

Abstract

The efficacy of antidepressant treatment of major depression remains a matter of controversy. A review of acute treatment studies suggests that for relatively more severe episodes of major depression, antidepressants are superior to treatment in the "placebo group;" however, there are numerous methodological confounds in the available literature. (Some recent, preliminary evidence suggests that antidepressants may also be of benefit in some less severely depressed populations).There is moderately strong evidence that, compared with placebo, maintenance antidepressant treatment reduces six-month relapse rates in major depression; however, it is less clear that antidepressants prevent actual recurrence of depression in the longer term. There is evidence of both over-use and under-use of antidepressant treatment, and there appears to be a "mismatch" between diagnosis and optimal treatment of depression in some clinical settings. Better designed studies are needed to resolve these uncertainties and to investigate such putative conditions as "oppositional tolerance" to long-term antidepressant treatment. The author advocates a conservative approach to antidepressant treatment, as well as a substantially extended "tapering" period when antidepressants are discontinued.

Entities:  

Keywords:  Antidepressants; acute treatment; maintenance treatment; oppositional tolerance; placebo effect; recurrence; relapse

Year:  2012        PMID: 22808447      PMCID: PMC3398684     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  41 in total

Review 1.  The mechanisms of tolerance in antidepressant action.

Authors:  Giovanni A Fava; Emanuela Offidani
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-20       Impact factor: 5.067

Review 2.  The abrupt discontinuation of antihypertensive treatment.

Authors:  S B Garbus; M A Weber; R T Priest; D D Brewer; F A Hubbell
Journal:  J Clin Pharmacol       Date:  1979 Aug-Sep       Impact factor: 3.126

3.  Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

Authors:  Steven D Hollon; Robert J DeRubeis; Richard C Shelton; Jay D Amsterdam; Ronald M Salomon; John P O'Reardon; Margaret L Lovett; Paula R Young; Kirsten L Haman; Brent B Freeman; Robert Gallop
Journal:  Arch Gen Psychiatry       Date:  2005-04

4.  Patient Stage of Change predicts outcome in a panic disorder medication trial.

Authors:  B D Beitman; N C Beck; W E Deuser; C S Carter; J R Davidson; R J Maddock
Journal:  Anxiety       Date:  1994

5.  Clinical implications of "subthreshold" depressive symptoms.

Authors:  P M Lewinsohn; A Solomon; J R Seeley; A Zeiss
Journal:  J Abnorm Psychol       Date:  2000-05

6.  Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

Authors:  A John Rush; Madhukar H Trivedi; Jonathan W Stewart; Andrew A Nierenberg; Maurizio Fava; Benji T Kurian; Diane Warden; David W Morris; James F Luther; Mustafa M Husain; Ian A Cook; Richard C Shelton; Ira M Lesser; Susan G Kornstein; Stephen R Wisniewski
Journal:  Am J Psychiatry       Date:  2011-05-02       Impact factor: 18.112

Review 7.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

Review 8.  The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.

Authors:  G R Heninger; P L Delgado; D S Charney
Journal:  Pharmacopsychiatry       Date:  1996-01       Impact factor: 5.788

9.  Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.

Authors:  M B Keller; J H Kocsis; M E Thase; A J Gelenberg; A J Rush; L Koran; A Schatzberg; J Russell; R Hirschfeld; D Klein; J P McCullough; J A Fawcett; S Kornstein; L LaVange; W Harrison
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

10.  Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.

Authors:  Paul W Andrews; Susan G Kornstein; Lisa J Halberstadt; Charles O Gardner; Michael C Neale
Journal:  Front Psychol       Date:  2011-07-07
View more
  2 in total

1.  Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time.

Authors:  B A A Bus; M L Molendijk; I Tendolkar; B W J H Penninx; J Prickaerts; B M Elzinga; R C O Voshaar
Journal:  Mol Psychiatry       Date:  2014-08-26       Impact factor: 15.992

2.  A Patient Stratification Approach to Identifying the Likelihood of Continued Chronic Depression and Relapse Following Treatment for Depression.

Authors:  Rob Saunders; Zachary D Cohen; Gareth Ambler; Robert J DeRubeis; Nicola Wiles; David Kessler; Simon Gilbody; Steve D Hollon; Tony Kendrick; Ed Watkins; David Richards; Sally Brabyn; Elizabeth Littlewood; Debbie Sharp; Glyn Lewis; Steve Pilling; Joshua E J Buckman
Journal:  J Pers Med       Date:  2021-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.